Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Gastritis Treatment Guidelines

First-Line Treatment Options

  • The American College of Gastroenterology recommends high-potency proton pump inhibitors (PPIs) as first-line treatment for gastritis, with options like esomeprazole or rabeprazole (20-40 mg twice daily) being most effective for symptom relief and healing 1
  • Recommended PPI options and dosages include rabeprazole: 20 mg twice daily, esomeprazole: 20-40 mg twice daily, and lansoprazole: 30 mg twice daily 1
  • PPIs should be taken 30 minutes before meals for optimal effectiveness 1

Treatment for H. pylori-Associated Gastritis

  • Bismuth quadruple therapy for 14 days is the preferred first-line treatment for H. pylori-associated gastritis due to increasing antibiotic resistance 1
  • Concomitant 4-drug therapy is an alternative when bismuth is unavailable 1
  • Triple therapy options should be guided by local resistance patterns 1
  • Higher-potency PPIs improve H. pylori eradication rates 1
  • Testing for H. pylori should be performed using non-invasive tests such as urea breath test or monoclonal stool antigen tests 1
  • Antibiotics in the "Access group" (amoxicillin, tetracycline, and metronidazole) have lower resistance potential 2
  • Eradication therapy should be administered for 14 days to maximize effectiveness 2
  • H. pylori eradication provides a significant improvement in symptom resolution compared to placebo 3

Treatment for NSAID-Induced Gastritis

  • The American College of Gastroenterology recommends using the lowest effective NSAID dose for the shortest duration to minimize risk 1
  • Add PPI therapy for gastroprotection in high-risk patients taking NSAIDs 1
  • Consider H. pylori eradication before starting long-term NSAID therapy 1
  • Misoprostol reduces NSAID-associated gastric ulcers by 74% but has side effects including diarrhea and abdominal pain 1

Adjunctive Treatments

  • Antacids provide rapid, temporary relief of symptoms and can be used on-demand for breakthrough symptoms 1
  • For patients with residual symptoms after successful H. pylori eradication, full-dose PPI therapy is recommended 1

Special Considerations

  • Inadequate PPI dosing and premature discontinuation of treatment should be avoided 1
  • Failure to address H. pylori infection when present should be avoided 1
  • Relying solely on symptom resolution without confirming H. pylori eradication should be avoided 1
  • Insufficient duration of antibiotic therapy for H. pylori (should be 14 days) should be avoided 2
  • Confirm H. pylori eradication after treatment with non-invasive testing 1
  • Gradual improvement of symptoms with fluctuations is expected with appropriate treatment 1
  • For persistent symptoms despite appropriate therapy, consider endoscopic evaluation to rule out other causes 1